HOME >> BIOLOGY >> NEWS
GlycoFi and Dartmouth report full humanization of yeast glycosylation pathway in Science

LEBANON, NH (September 7, 2006) - For the first time, scientists have engineered yeast cells capable of producing a broad repertoire of recombinant therapeutic proteins with fully human sugar structures (glycosylation). These sugar structures ensure a glycoprotein's biological activity and half-life and to date, have necessitated the expression of therapeutic glycoproteins in mammalian hosts. The accomplishment reported today has the potential to eliminate the need for mammalian cell culture, while improving control over glycosylation, and improving performance characteristics of many therapeutic proteins.

Scientists from GlycoFi, Inc., a wholly owned subsidiary of Merck & Co., Inc., and their collaborators at Dartmouth-Hitchcock Medical Center published their report detailing the genetic engineering of the yeast Pichia pastoris to secrete human glycoproteins with fully complex, terminally sialyated N-glycans today in the September 8, 2006 issue of the journal Science. To demonstrate the utility of the engineered yeast strains, recombinant erythropoietin (Epo), a protein that stimulates the production of red blood cells, was expressed, purified and its activity demonstrated in vivo.

"Re-engineering the yeast glycosylation system to fully replicate the full repertoire of human glycosylation reactions has been a challenging six year effort that many doubted could be accomplished," said Tillman Gerngross, Ph.D., chief scientific officer of GlycoFi and professor of Bioengineering at Dartmouth College.

"This achievement required both the elimination of yeast-specific glycosylation reactions and the introduction of 14 heterologous genes, making this one of the most complex cellular engineering endeavors reported to date", said Stephen Hamilton, Ph.D., the lead author of the study and a senior scientist at GlycoFi.

Yeast offers numerous advantages as a recombinant protein expression system when compared to mammalian cell
'"/>

Contact: Joan Kureczka
JKureczka@comcast.net
415-821-2413
Kureczka/Martin Associates
7-Sep-2006


Page: 1 2

Related biology news :

1. Dartmouth and GlycoFi report full humanization of therapeutic proteins from yeast
2. GlycoFi announces the first production of antibodies with human glycosylation in yeast
3. Dartmouth, GlycoFi researchers make leap in protein bioengineering
4. Dartmouth professor makes case for ethically universal stem cell lines
5. Plants that produce more vitamin C may result from UCLA-Dartmouth discovery
6. Vitamin extends life in yeast, Dartmouth Medical School researchers find
7. Dartmouth researchers find that arsenic triggers unique mechanism in rare leukemia
8. Dartmouth researchers find that low doses of arsenic have broad impact on hormone activity
9. Dartmouth researchers identify a gene that enhances muscle performance
10. Dartmouth study contributes to research addressing malnutrition and iron deficiency
11. Genetic variation impacts aspirins effectiveness in preventing colon cancer, Dartmouth study finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics leader hc1® ... uniquely combines lab testing insights and hc1’s exclusive Local Risk Index in a ... safety of employees returning to the workplace. , “Some of the best ways ...
(Date:5/25/2020)... OXFORD, United Kingdom (PRWEB) , ... May 22, 2020 , ... ... test (assay) for the detection of SARS-CoV-2, the virus that causes COVID-19. ... cater to on-demand analysis of smaller sample numbers, to very large numbers of samples. ...
(Date:5/21/2020)... ... May 20, 2020 , ... Law Enforcement has always been a ... of us. The positions of these men and women put them constantly in harm’s ... following rules precisely. Officers have always had to face very high daily stress. Now, ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, developer of ... Solution, a highly accurate, contact tracing solution for identification of employees who ... a core disease control measure, is a key strategy for preventing further spread ...
(Date:5/30/2020)... ... May 29, 2020 , ... Medrio, Inc., the leading ... markets, has enabled Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics ... their first patient in (FPI) in just seven days. The Cytovale technology will ...
(Date:5/26/2020)... Calif. (PRWEB) , ... May 26, 2020 , ... ... the most recognized brand of smart garage door openers, announce a new integration to ... of Wi-Fi enabled garage door openers powered by Aladdin Connect® can now be controlled ...
(Date:5/21/2020)... Calif. (PRWEB) , ... May 20, 2020 , ... ... the addition of Simon Prakash, who will serve as the company’s executive vice ... at a time when Exo is disrupting the medical imaging space, bringing more ...
Breaking Biology Technology:
Cached News: